Your browser doesn't support javascript.
loading
Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study.
McAlindon, T E; Schmidt, U; Bugarin, D; Abrams, S; Geib, T; DeGryse, R E; Kim, K; Schnitzer, T J.
Afiliação
  • McAlindon TE; Division of Rheumatology, Tufts Medical Center, Boston, MA, USA. Electronic address: TMcAlindon@tuftsmedicalcenter.org.
  • Schmidt U; CCBR Ballerup, Bioclinica Research Network, Denmark. Electronic address: Ulla.Schmidt@bioclinica.com.
  • Bugarin D; Allergan Plc, Irvine, CA, USA. Electronic address: Bugarin_Denise@Allergan.com.
  • Abrams S; Allergan Plc, Irvine, CA, USA. Electronic address: Abrams_Steve@Allergan.com.
  • Geib T; Allergan Plc, Irvine, CA, USA. Electronic address: Till.Geib@Allergan.com.
  • DeGryse RE; Allergan Plc, Irvine, CA, USA. Electronic address: Degryse_Ronald@Allergan.com.
  • Kim K; Allergan Plc, Irvine, CA, USA. Electronic address: Kim_Kimmie@Allergan.com.
  • Schnitzer TJ; Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: tjs@northwestern.edu.
Osteoarthritis Cartilage ; 26(10): 1291-1299, 2018 10.
Article em En | MEDLINE | ID: mdl-29753118

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artralgia / Toxinas Botulínicas Tipo A / Osteoartrite do Joelho / Articulação do Joelho Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artralgia / Toxinas Botulínicas Tipo A / Osteoartrite do Joelho / Articulação do Joelho Idioma: En Ano de publicação: 2018 Tipo de documento: Article